Details for: PREVNAR 20
Company: PFIZER CANADA ULC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02527049 | PREVNAR 20 | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F; CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN | 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 4.4 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 51 MCG / 0.5 ML | SUSPENSION | INTRAMUSCULAR |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.